NIH/National Institute of Allergy and Infectious Diseases

HIV vaccine trial launches in South Africa

A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental ...

Feb 18, 2015
popularity 5 / 5 (2) | comments 0

Skin microbes trigger specific immune responses

New research in mice shows that the immune system in the skin develops distinct responses to the various microbes that naturally colonize the skin, referred to as commensals. A team led by scientists at the National Institute ...

Jan 05, 2015
popularity 5 / 5 (5) | comments 0

Estrogen worsens allergic reactions in mice

Estradiol, a type of estrogen, enhances the levels and activity in mice of an enzyme that drives life-threatening allergic reactions, according to researchers from the National Institute of Allergy and Infectious ...

Dec 29, 2014
popularity 5 / 5 (3) | comments 0

Model explains why HIV prevention dosing differs by sex

A mathematical model developed by NIH grantees predicts that women must take the antiretroviral medication Truvada daily to prevent HIV infection via vaginal sex, whereas just two doses per week can protect men from HIV infection ...

Oct 30, 2014
popularity 5 / 5 (1) | comments 0